Physician
O'shea, Jennifer
O'shea, Jennifer was paid $1.43M by Medicaid between Jan 2018 and Mar 2023, across 37 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 24% of everything it billed.
33Billing provider infoO'SHEA, JENNIFER
LOWELL, MA 01852
LOWELL, MA 01852
33aNPI1942264387assigned 04/13/2006
33bProvider typePediatrics Physician
28Total paid$1.43M
24GClaims37,832
24DCodes billed37
24AFirst – last monthJan 2018 – Mar 2023
Compared with peers
Next to other Pediatrics Physician providers in Massachusetts
Rank by total paid#49 of 1,273
Median peer was paid$24K
This provider vs. median60×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 7,298 | $292K | |
| 2019 | 7,039 | $245K | |
| 2020 | 6,338 | $224K | |
| 2021 | 6,902 | $248K | |
| 2022 | 8,277 | $341K | |
| 2023 | 1,978 | $79K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 24% | 6,032 | 5,864 | $349K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 20% | 2,995 | 2,897 | $281K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 9.6% | 3,367 | 3,348 | $137K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 5.8% | 1,027 | 1,026 | $83K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 5.6% | 988 | 988 | $81K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 5.1% | 1,433 | 1,412 | $73K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 4.2% | 676 | 676 | $60K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 3.4% | 620 | 616 | $48K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 3.3% | 584 | 580 | $47K |
| S0302 | Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) | 2.5% | 3,998 | 3,991 | $36K |
| 90461 | 2.5% | 945 | 941 | $35K | |
| 92558 | 1.9% | 1,144 | 1,141 | $28K |
25 more codes
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1.6% | 993 | $23K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.4% | 1,989 | $21K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.4% | 616 | $19K |
| 96127 | 1.2% | 1,696 | $17K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.1% | 1,220 | $16K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,004 | $13K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 732 | $13K |
| 99173 | <1% | 419 | $7K | |
| 87081 | <1% | 889 | $7K | |
| 83655 | <1% | 545 | $6K | |
| 99177 | <1% | 494 | $6K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 796 | $6K |
| 94760 | <1% | 1,935 | $4K | |
| 36416 | <1% | 359 | $3K | |
| 0071A | <1% | 59 | $3K | |
| 87634 | <1% | 19 | $1K | |
| 99188 | <1% | 39 | $1K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 12 | $967.15 |
| 0072A | <1% | 15 | $688.20 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 30 | $457.80 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 12 | $322.32 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 12 | $322.32 |
| 81003 | <1% | 95 | $199.16 | |
| 99000 | <1% | 12 | $12.00 | |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | <1% | 31 | $9.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.